Digestive & Intestinal Remedies (Pharmacies) - Europe

  • Europe
  • Revenue in the Digestives & Intestinal Remedies market is projected to reach US$5.09bn in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2028) of 3.01%, resulting in a market volume of US$5.73bn by 2028.
  • In global comparison, most revenue will be generated in China (US$3,367.00m in 2024).
  • In relation to total population figures, per person revenues of US$6.03 are generated in 2024.

Key regions: United States, South Korea, Japan, Canada, India

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Digestive & Intestinal Remedies (Pharmacies) market in Europe is experiencing steady growth due to several factors.

Customer preferences:
Customers in Europe are increasingly seeking digestive and intestinal remedies from pharmacies due to the convenience and accessibility they offer. Pharmacies provide a wide range of over-the-counter products that cater to various digestive issues, such as indigestion, heartburn, and constipation. In addition, customers trust the expertise of pharmacists who can provide personalized advice and recommendations based on their specific needs. This has led to a growing preference for purchasing digestive and intestinal remedies from pharmacies rather than other retail channels.

Trends in the market:
One of the key trends in the Digestive & Intestinal Remedies (Pharmacies) market in Europe is the increasing demand for natural and herbal remedies. Customers are becoming more health-conscious and are seeking products that are perceived as safer and more sustainable. As a result, there is a growing demand for digestive and intestinal remedies that are made from natural ingredients and do not contain artificial additives. This trend is driving the development of new products and formulations in the market. Another trend in the market is the rising popularity of probiotics and prebiotics. Probiotics are live bacteria that are beneficial for the digestive system, while prebiotics are non-digestible fibers that promote the growth of beneficial bacteria in the gut. These products are gaining traction among customers who are looking for long-term solutions to improve their digestive health. Pharmacies are capitalizing on this trend by offering a wide range of probiotic and prebiotic supplements.

Local special circumstances:
In certain European countries, there are specific local circumstances that are influencing the development of the Digestive & Intestinal Remedies (Pharmacies) market. For example, in countries with a high prevalence of lactose intolerance, there is a growing demand for lactase supplements that help digest lactose. Similarly, in countries with a high consumption of spicy food, there is a higher demand for remedies that relieve heartburn and indigestion.

Underlying macroeconomic factors:
The growth of the Digestive & Intestinal Remedies (Pharmacies) market in Europe is also influenced by underlying macroeconomic factors. For instance, an aging population in many European countries is driving the demand for digestive and intestinal remedies. Older adults are more prone to digestive issues and are more likely to seek remedies to alleviate their symptoms. In addition, increasing disposable incomes in Europe are enabling customers to spend more on healthcare products, including digestive and intestinal remedies. In conclusion, the Digestive & Intestinal Remedies (Pharmacies) market in Europe is growing due to customer preferences for convenience and accessibility, as well as the increasing demand for natural and herbal remedies. The market is also influenced by local special circumstances, such as the prevalence of specific digestive issues in certain countries. Furthermore, underlying macroeconomic factors, such as an aging population and increasing disposable incomes, are driving the growth of the market.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)